Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841269 · ClinicalTrials.gov registry record · Phase 2
Oral Uridine for Treatment of Bipolar Depression in Adolescents
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
NCT00841269 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 42 participants.
The verdict
NCT00841269, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of the study is to see if the investigational medication uridine reduces depression symptoms in adolescents with bipolar disorder. Uridine is a naturally occurring chemical that is made by the human liver. Uridine is part of a family of compounds called pyrimidines, and is normally involved in many of the body's processes such as the use of energy by cells. Uridine is considered experimental, because it has not been approved by the U.S. Food and Drug Administration (FDA) to treat bipolar depression in adolescents. The study will use standard methods of assessing adolescent's mood, such as rating scales and questionnaires. In addition, the study will use Magnetic Resonance Imaging Spectroscopy (MRI/MRS) brain scans to see if levels of certain chemicals in the brain change when adolescents are treated with uridine. These scans use a magnet to create images of the brain, and do not expose patients to radiation.
Interventions
- DRUG Uridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00841269
The ClinicalTrials.gov registry entry for NCT00841269 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Uridine is the first listed.
NCT00841269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00841269 about?
NCT00841269 is a clinical study titled "Oral Uridine for Treatment of Bipolar Depression in Adolescents". The purpose of the study is to see if the investigational medication uridine reduces depression symptoms in adolescents with bipolar disorder. Uridine is a naturally occurring chemical that is made by the human liver. Uridine is part of a family of compounds called pyrimidines, and is normally invol...
What is the current status of trial NCT00841269?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2009-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00841269?
The interventions under investigation include: Uridine (DRUG).
Who is sponsoring clinical trial NCT00841269?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.